Warfarin ineffective as symptomatic therapy for erythropoietic protoporphyria

Australas J Dermatol. 2019 Nov;60(4):e360-e361. doi: 10.1111/ajd.13033. Epub 2019 Mar 27.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Aortic Valve Stenosis / surgery
  • Australia
  • Cytochrome P-450 CYP2C9 / genetics*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Heart Valve Prosthesis Implantation / methods
  • Humans
  • Male
  • Middle Aged
  • Pilot Projects
  • Postoperative Care / methods
  • Protoporphyria, Erythropoietic / drug therapy*
  • Protoporphyria, Erythropoietic / genetics*
  • Retrospective Studies
  • Risk Assessment
  • Sampling Studies
  • Treatment Failure
  • Warfarin / therapeutic use*
  • Young Adult

Substances

  • Warfarin
  • CYP2C9 protein, human
  • Cytochrome P-450 CYP2C9